Form DEFA14A CAPITAL CITY BANK GROUP
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934 (Amendment No. )
|
|
|
|
|
|
|
|
|
|
|
|
☒
|
|
|
Filed by the Registrant
|
|
|
☐
|
|
|
Filed by a Party other than the Registrant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Check the appropriate box:
|
|||
|
☐
|
|
|
Preliminary Proxy Statement
|
|
☐
|
|
|
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
|
|
☐
|
|
|
Definitive Proxy Statement
|
|
☒
|
|
|
Definitive Additional Materials
|
|
☐
|
|
|
Soliciting Material Under Rule 14a-12
|
|
|
|
|
|

Capital City Bank Group, Inc
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if Other than the Registrant)
|
|
|||
|
Payment of Filing Fee (Check the appropriate box):
|
|||
|
☒
|
|
|
No fee required.
|
|
☐
|
|
|
Fee paid previously with preliminary materials.
|
|
☐
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11.
|

Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Capital City Bank Group (CCBG) Declares $0.27 Quarterly Dividend; 2.1% Yield
- Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products
- Imperium AI CEO Shazir Mucklai on Major Potential in Dyadic (NASDAQ: DYAI), Calls Board Meeting to Discuss Next Steps
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share